Koers Panacos Pharmaceuticals, Inc. Other OTC
Aandelen
PANC
US69811Q1067
Biotechnologie & Medisch Onderzoek
Omzet 2006 | 284K 262K | Omzet 2007 | 180K 166K | Marktkapitalisatie | 42,29 mln. 39 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | -38 mln. -35,04 mln. | Nettowinst (verlies) 2007 | -37 mln. -34,12 mln. | EV/omzet 2006 | 504 x |
Nettoliquiditeiten 2006 | 60,4 mln. 55,7 mln. | Nettoliquiditeiten 2007 | 32,58 mln. 30,05 mln. | EV/omzet 2007 | 53,9 x |
K/w-verhouding 2006 |
-5,32
x | K/w-verhouding 2007 |
-1,12
x | Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John R. Barr
CEO | Chief Executive Officer | 67 | - |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |